FDA warning of coma, death risk from high blood acid level complications from popular diabetes drugs
June 8th, 2015
The Food and Drug Administration has issued a warning about a risk of life-threatening complications in patients taking a new …
Tags: diabetes, Farxiga, Glyxambi, Invokamet, Invokana, Janumet, Januvia, Jardiance, ketoacidosis, SGLT2 inhibitors, Xigduo XR
Posted in HO&P Legal Blog, Januvia and Janumet, Pharmaceutical Liability |